Enterprise Value
-4.697M
Cash
147M
Avg Qtr Burn
-16.86M
Short % of Float
2.81%
Insider Ownership
0.06%
Institutional Own.
97.76%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
PGN-EDO51 Details Duchenne muscular dystrophy | Phase 2 Data readout | |
PGN-EDODM1 Details Myotonic Dystrophy Type 1 | Phase 1 Initiation |